87 related articles for article (PubMed ID: 1509986)
1. [Immunologic clinical evaluation of a biological response modifier, AM3, in the treatment of childhood infectious respiratory pathology].
Sánchez Palacios A; García Marrero JA; Schamann F
Allergol Immunopathol (Madr); 1992; 20(1):35-9. PubMed ID: 1509986
[TBL] [Abstract][Full Text] [Related]
2. The immunosenescent phenotype in mice and humans can be defined by alterations in the natural immunity reversal by immunomodulation with oral AM3.
Villarrubia VG; Moreno Koch MC; Calvo C; González S; Alvarez-Mon M
Immunopharmacol Immunotoxicol; 1997 Feb; 19(1):53-74. PubMed ID: 9049659
[TBL] [Abstract][Full Text] [Related]
3. [AM3 (a biological response modifier) in the treatment of recurrent aphthous stomatitis. Clinical evaluation and preliminary studies on NK (CD16) cells and their pathogenic role in the syndrome].
Camacho F; Elorza FL; Ortega M; Elorza MA; Sada G; Villarrubia VG
Rev Clin Esp; 1991 May; 188(8):403-8. PubMed ID: 1832500
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow recuperation by AM3 in breast cancer patients submitted to aggressive adjuvant treatment. A preliminary report.
Millá A; Sanchiz F; Sada G; Villarrubia VG
Anticancer Res; 1986; 6(4):865-8. PubMed ID: 3752963
[TBL] [Abstract][Full Text] [Related]
5. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
6. Pidotimod in the treatment of recurrent respiratory infections in paediatric patients.
Careddu P; Mei V; Venturoli V; Corsini A
Arzneimittelforschung; 1994 Dec; 44(12A):1485-9. PubMed ID: 7857348
[TBL] [Abstract][Full Text] [Related]
7. [Current data on the etiology and etiopathogenetic treatment of infantile asthma].
Seropian E; Bolocan E
Pediatria (Bucur); 1974 Jan; 23(1):85-90. PubMed ID: 4840991
[No Abstract] [Full Text] [Related]
8. Pidotimod in the treatment of patients affected by bacterial exacerbations of chronic bronchitis.
Pozzi E; Dolcetti A; Orlandi O; Cirianni C; Moreo G; Piacenza G; Rampulla C; Fugazza L; Scarpazza G
Arzneimittelforschung; 1994 Dec; 44(12A):1495-8. PubMed ID: 7857350
[TBL] [Abstract][Full Text] [Related]
9. [Mixed vaccination (polyvalent vaccine and Subtivaccine) in the treatment of allergic bacterial processes (bronchial asthma and recurrent catarrhal infections) of the respiratory tract in children].
Nowak T
Folia Clin Int (Barc); 1969 May; 19(5):297-303. PubMed ID: 5804061
[No Abstract] [Full Text] [Related]
10. [Study of a biological response modifier in the treatment of infections of the ORL region].
Hötzinger H
Acta Otorrinolaringol Esp; 1988; 39(2):135-8. PubMed ID: 3273773
[No Abstract] [Full Text] [Related]
11. [Place of microbial infection in respiratory allergy in children].
Bernard R; Gratecos L; Raquet J; Allard J; Jaubert R
Ann Pediatr (Paris); 1969 May; 16(5):343-7. PubMed ID: 4184534
[No Abstract] [Full Text] [Related]
12. [Clinical and etiopathogenetical pecularities of allergic asthma in children].
De Luca R; Gemelli M
Pediatria (Napoli); 1972; 80(2):101-23. PubMed ID: 5070929
[No Abstract] [Full Text] [Related]
13. [Spasmolytic and mucolytic agents in the treatment of acute dyspneic pneumopathies in children].
Manicatide ET; Căpraru H
Pediatria (Bucur); 1973; 22(4):357-60. PubMed ID: 4761443
[No Abstract] [Full Text] [Related]
14. [Cough in the child and in the adult (with treatment)].
Menetrey C; Melloni B
Rev Prat; 2003 Nov; 53(18):2064-70. PubMed ID: 15008223
[No Abstract] [Full Text] [Related]
15. The usefulness of transfer factor in asthma associated with frequent infections.
Khan A; Sellars W; Grater W; Graham MF; Pflanzer J; Antonetti A; Bailey J; Hill NO
Ann Allergy; 1978 Apr; 40(4):229-32. PubMed ID: 345886
[TBL] [Abstract][Full Text] [Related]
16. Rhinitis and asthma co-morbidity in respiratory allergy due to house dust mite: results of an observational open controlled parallel group study in real-life setting.
Marogna M; Spadolini I; Massolo A
Eur Ann Allergy Clin Immunol; 2005 Apr; 37(4):135-42. PubMed ID: 15916014
[TBL] [Abstract][Full Text] [Related]
17. [Socioeconomic evaluation of the effect of rhDNase on the cost of treating infections of the respiratory tract in patients with cystic fibrosis].
von der Schulenburg JM; Greiner W; von der Hardt H
Med Klin (Munich); 1995 Apr; 90(4):220-4. PubMed ID: 7776934
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of pidotimod in the treatment of recurrent respiratory infections in children.
Caramia G; Clemente E; Solli R; Mei V; Cera R; Carnelli V; Venturoli V; Corsini A
Arzneimittelforschung; 1994 Dec; 44(12A):1480-4. PubMed ID: 7857347
[TBL] [Abstract][Full Text] [Related]
19. Chronic cough: an approach to management.
Corrao WM
Compr Ther; 1986 Jul; 12(7):14-9. PubMed ID: 2873919
[TBL] [Abstract][Full Text] [Related]
20. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
